Open Access
Table III
Critical analysis of the literature on the efficacy of botulinum toxin in the management of overdrooling in children with cerebral motor problems.
Reference | Objective | Type of study | No. | BT dose | Duration | Judgment criteria | Muscle site salivary gland | Validity |
---|---|---|---|---|---|---|---|---|
Reid, 2008 [21] | Efficiency: Injection versus no injection | Rand, CT, multicenter | 48 | 100 U | 12 months | Subjective: Q ° parents | P + Sb | S |
6–18 years | Botox** | |||||||
Alrefai, 2008 [22] | Efficacy: Injection versus placebo | Rand, DB, CT | 24 | 240 U | 4 months | Subjective: Q ° nurse | P + Sb | S |
21 months to 7 years | Dysport** | |||||||
Jongerius, 2004 [23] | Efficiency: injection versus Scopolamine | Rand, CT | 45 | 50 U | 24 months | Subjective: Q ° parents | Sb | S |
3–17 years | Botox* | Objective: DQ | Injection>scopolamine | |||||
Suskind, 2002 [24] | Efficacy: injection in different glands | CT, prospective | 22 | 30 U | 1 month | Objective: DQ | P + Sb | S |
8–21 years | Botox* | Cotton salivary test | NS difference | |||||
Basciani, 2011 [25] | Efficiency: 3 different doses versus placebo | Rand, CT, prospective | 27 | 1500 U, 3000 U, 5000 U, Neuroblo** | 3 months | Subjective: Q ° parents | P + Sb | S |
6 months to 7 years | Objective: number of bottles |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.